Name | Kinney Drugs #30 |
---|---|
Organization Name | Kph Healthcare Services Inc |
Location | 905 Coffeen St, Watertown, New York 13601 |
Type | Pharmacy |
Phone | (315) 788-9366 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In a landmark study published this week in the BMJ, Finnish researchers show that one of the most common surgical procedures in the Western world is probably unnecessary.
A wireless kit, comprising headphones, a microphone, and an app might be a cheap alternative to the usual treatment of the common temporary hearing loss in kids, popularly known as 'glue ear,' finds a small study, published in the online journal BMJ Innovations.
ImmunoCellular Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has given clearance to a physician sponsored investigative new drug (IND) application to initiate a Phase I clinical trial of ICT-121, IMUC's novel dendritic-cell-based vaccine targeting CD-133, an antigen that is highly expressed by multiple solid tumors.
In addition to reducing headache frequency and severity, surgical treatment for migraine leads to significant improvements in everyday functioning and coping ability, according to a study in the January issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons.
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, ophthalmic, and liver diseases, traded on the Tel Aviv Stock Exchange announced today that it has commenced patient enrolment in a phase 2/3 clinical trial of CF101 for the treatment of Psoriasis.
› Verified 2 days ago
NPI Number | 1952418675 |
Organization Name | KPH HEALTHCARE SERVICES, INC. |
Doing Business As | KINNEY DRUGS #30 |
Type | Pharmacy |
Address | 905 Coffeen St, Watertown, NY 13601 |
Phone Number | 315-788-9366 |
News Archive
In a landmark study published this week in the BMJ, Finnish researchers show that one of the most common surgical procedures in the Western world is probably unnecessary.
A wireless kit, comprising headphones, a microphone, and an app might be a cheap alternative to the usual treatment of the common temporary hearing loss in kids, popularly known as 'glue ear,' finds a small study, published in the online journal BMJ Innovations.
ImmunoCellular Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has given clearance to a physician sponsored investigative new drug (IND) application to initiate a Phase I clinical trial of ICT-121, IMUC's novel dendritic-cell-based vaccine targeting CD-133, an antigen that is highly expressed by multiple solid tumors.
In addition to reducing headache frequency and severity, surgical treatment for migraine leads to significant improvements in everyday functioning and coping ability, according to a study in the January issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons.
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, ophthalmic, and liver diseases, traded on the Tel Aviv Stock Exchange announced today that it has commenced patient enrolment in a phase 2/3 clinical trial of CF101 for the treatment of Psoriasis.
› Verified 2 days ago
News Archive
In a landmark study published this week in the BMJ, Finnish researchers show that one of the most common surgical procedures in the Western world is probably unnecessary.
A wireless kit, comprising headphones, a microphone, and an app might be a cheap alternative to the usual treatment of the common temporary hearing loss in kids, popularly known as 'glue ear,' finds a small study, published in the online journal BMJ Innovations.
ImmunoCellular Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has given clearance to a physician sponsored investigative new drug (IND) application to initiate a Phase I clinical trial of ICT-121, IMUC's novel dendritic-cell-based vaccine targeting CD-133, an antigen that is highly expressed by multiple solid tumors.
In addition to reducing headache frequency and severity, surgical treatment for migraine leads to significant improvements in everyday functioning and coping ability, according to a study in the January issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons.
Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, ophthalmic, and liver diseases, traded on the Tel Aviv Stock Exchange announced today that it has commenced patient enrolment in a phase 2/3 clinical trial of CF101 for the treatment of Psoriasis.
› Verified 2 days ago
Bolton's Pharmacy Ii Type: Medicare Supplier Location: 1320 Washington St, Watertown, New York 13601 Phone: (315) 782-1992 | |
Bolton's Pharmacy Inc Type: Long Term Care Pharmacy Location: 128 W Main St, Watertown, New York 13601 Phone: (315) 782-5961 | |
Cvs Pharmacy #17328 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 21800 Towne Center Dr, Watertown, New York 13601 Phone: (315) 786-2541 | |
Visionworks Type: Medicare Supplier Location: 1125 Arsenal St, Watertown, New York 13601 Phone: (315) 788-5020 | |
Price Chopper Pharmacy 102 Type: Pharmacy Location: 1283 Arsenal St, Watertown, New York 13601 Phone: (315) 786-2947 |